The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
Monkeypox Clinical Forum 2022
Related Enduring Materials
What's New
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
About this Program
Several countries in West and Central Africa have been reporting human monkeypox infection since the 1970s but despite this, it has remained a neglected tropical infection that has been underfunded and under-researched. Sporadic exported cases outside of Africa have occurred several times over the years with very short chains of (mainly household or HCW) transmission beyond the index case. This situation changed in early May 2022 when the first cases of this global outbreak were reported to the WHO.
Since then, there have been near-simultaneous outbreaks in multiple countries which now affect at least all 6 WHO regions and at least 79 countries. The WHO declared the situation a PHIEC in late July. The outbreaks are occurring almost exclusively in sexually active gay and bisexual men who have sex with men (GBMSM). Infections in previously affected African countries are now accounting for 2% of the globally reported cases.
There is an urgent need for education for clinicians in most countries who may never have seen or treated anyone with human monkeypox infection. There are many unanswered questions about transmission, asymptomatic disease, treatment, and vaccine efficacy for pre- and post-exposure prophylaxis, not to mention the evolution of a new phylogenetic classification nomenclature.
This program will aim to provide rapid education for those caring for people with human monkeypox infection from the perspective of clinicians previously and newly experienced with the disease.
Program Director
General Information
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Microbiologists; and
-Specialized nurses.
-Outline our current knowledge of the epidemiology of the Monkeypox outbreak;
-Categorize the various clinical symptoms for case recognition/definition; and
-Reflect on the therapeutical options for treatment and prevention.
Practical Information
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Program Director
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in Monkeypox.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Federica Ressa at federica@amededu.com or call +31 30 230 7140.
Become an Endorser
If you would like your organization to support the Monkeypox Clinical Forum 2022 as an endorser or media partner, please contact Ms. Vicky Cheng at vicky.cheng@amededu.com.
Endorsers
The Monkeypox Clinical Forum 2022 was endorsed by the following organizations: